Skip to content
OpenCapital
Get started

InfuSystem Holdings INFU Device Solutions — Net revenues - external

Similar metrics at other companies

Itron logo
ITRIDevice Solutions — Revenue
$124.38M-1.2%
ResMed logo
RMDDevices — Net revenue by segment
$1.47B+8.8%
AngioDynamics logo
ANGOMed Device — Net Sales
$41.14M+1.2%
Itron logo
ITRIDevice Solutions — Total cost of revenues
$80.36M-8.8%
Bausch + Lomb logo
BLCODevices — Total revenues
$480M+7.1%
Emerson Electric logo
EMRIntelligent Devices — Sales, excluding intersegment eliminations
$2.51B+2.2%

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept infu:NetRevenuesExternal.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's device solutions — net revenues - external.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's device solutions — net revenues - external?
InfuSystem Holdings (INFU) reported device solutions — net revenues - external of $11.58M in Q1 2026.
How has InfuSystem Holdings's device solutions — net revenues - external changed year-over-year?
InfuSystem Holdings's device solutions — net revenues - external decreased by 16.9% year-over-year, from $13.94M to $11.58M.
What is the long-term trend for InfuSystem Holdings's device solutions — net revenues - external?
Over 4 years (2021 to 2025), InfuSystem Holdings's device solutions — net revenues - external has grown at a 11.5% compound annual growth rate (CAGR), from $36.78M to $56.9M.
What does device solutions — net revenues - external mean?
Revenue earned by the Device Solutions segment from transactions with third-party customers outside of the consolidated entity. This is a key indicator of the segment's ability to compete and generate demand in the broader healthcare market.